Keeping you up to date on your investment
Follow the heartbeat of our mission as we strive to transform the lives of heart failure patients. Join our journey to redefine the landscape of cardiac health and help create a brighter future for patients worldwide.
Share price chart
Presentations & Webinars
SEC Filings
Date
Announcement
Download
November 13, 2024
SC 13G
November 13, 2024
SC 13G Statement of Beneficial Ownership by Certain Investors
November 12, 2024
10-Q Quarterly Report (ending Sept 30, 2024)
October 28, 2024
S-8 (Securities to be offered to employees in employee benefits plans)
October 23, 2024
10-12G/A2 (Registration of securities)
ASX Financial Update
Date
Announcement
Download
August 1, 2024
Pivotal SOLVE-CRT Study Results Published in JAMA Cardiology
July 30, 2024
Form 10 filing for U.S. Registration with SEC
July 25, 2024
Q2 2024 Quarterly Activity 4C
May 30, 2024
EBR Annual Meeting 2024
May 30, 2024
EBR Results of Annual Meeting 2024
News
Corporate governance
The EBR Board of Directors is responsible to shareholders for the overall governance and performance of the company.
The roles and responsibilities of the Board of Directors, Board Committees, management and operating subsidiaries have been established through Board-approved charters and formal delegations of authority.
The Board and Committee Charters and the Delegations of Authority provide the basis for the good governance of the company and operate in conjunction with the Constitution of the company, the Corporations Act and other relevant laws.